Inside our bones, an extraordinary process is taking place every moment of every day. Deep within the soft tissue known as bone marrow, the body continuously produces millions of new blood cells.
These cells carry oxygen, fight infections, stop bleeding, and help keep every organ working properly. Most people never think about this hidden activity, yet it is one of the most important systems that keeps us alive.
Bone marrow depends on a carefully balanced network of cells. At the center are blood stem cells, which have the special ability to create all the different types of blood cells the body needs.
Surrounding these stem cells are supportive cells that provide nutrients, protection, and signals that guide normal growth. Immune cells and chemical messengers also help maintain a healthy environment. When all of these parts work together, blood production remains stable and efficient.
As people get older, however, this balance can begin to change. Aging affects many tissues throughout the body, and bone marrow is no exception. Years of wear and tear, long-term low-level inflammation, and genetic changes that naturally accumulate with age can gradually disrupt communication between cells.
One condition linked to these age-related changes is called clonal hematopoiesis of indeterminate potential, or CHIP. Although the name sounds complicated, the basic idea is simple.
In people with CHIP, certain blood stem cells acquire mutations that give them a growth advantage. These altered cells begin to multiply more than normal stem cells and gradually take up more space in the bone marrow.
What makes CHIP particularly interesting is that most people who have it feel completely healthy. There are usually no obvious symptoms. Yet the condition becomes increasingly common with age. Research suggests that about one in five people over the age of 60 has CHIP, and the condition is found in nearly one-third of people over 80.
Even though CHIP often causes no immediate problems, it is not entirely harmless. People with CHIP face a higher risk of developing blood cancers later in life. Studies have also linked the condition to heart disease and an increased risk of early death.
Another serious disorder connected to abnormal blood stem cells is myelodysplastic syndrome, commonly known as MDS. In this condition, the bone marrow loses its ability to produce healthy blood cells efficiently.
Patients may experience tiredness, repeated infections, easy bruising, or bleeding problems. Around 30 percent of people with MDS eventually develop acute myeloid leukemia, a fast-growing and potentially life-threatening blood cancer.
For many years, scientists focused mainly on the mutations inside blood stem cells themselves. They believed these genetic changes were the main drivers of disease. However, an important question remained unanswered. Could the environment surrounding the stem cells also play a major role in helping disease develop?
To investigate this possibility, an international team of researchers conducted a detailed study of bone marrow samples from healthy individuals and patients with MDS.
The study was led by Judith Zaugg from EMBL and the University of Basel, together with Borhane Guezguez from the University Medical Center Mainz. The researchers used samples collected in Germany through a large project examining blood health in older adults.
Using advanced technologies, the scientists examined individual cells in remarkable detail. They analyzed genes, proteins, and the physical locations of different cell types within the bone marrow. This allowed them to build a highly detailed map of how the bone marrow environment changes during the earliest stages of disease.
The findings revealed something unexpected. Before clear signs of disease appeared, the normal support cells in the bone marrow had already begun to change. Healthy helper cells that normally nurture blood stem cells were gradually replaced by a different group of support cells that promoted inflammation.
These altered support cells produced large amounts of inflammatory substances. They also attracted immune cells, particularly certain types of T cells that respond strongly to inflammatory signals. Together, these cells created a self-sustaining cycle of inflammation inside the bone marrow.
This chronic inflammation had serious consequences. It disrupted the normal production of healthy blood cells and changed the structure of the bone marrow itself. Most importantly, it created conditions that allowed mutated stem cells to thrive and expand more easily.
One of the most surprising discoveries was that the mutated blood cells did not appear to be the primary cause of the inflammation. Instead, the surrounding bone marrow environment seemed to become unhealthy first. This damaged environment then encouraged the growth and survival of abnormal stem cells.
The researchers also found that important signaling pathways that normally help keep blood stem cells functioning properly were weakened in patients with MDS. Without these signals, the system that controls blood production began to fail, helping explain why bone marrow function declines during disease.
The findings support a broader scientific concept known as “inflammaging.” This term describes the slow, ongoing inflammation that develops with age and contributes to many age-related diseases, including cancer, cardiovascular disease, and metabolic disorders.
The study suggests that bone marrow may play a much larger role in inflammaging than previously thought.
These discoveries could have important implications for future treatments. Instead of focusing only on eliminating abnormal cells, doctors may one day be able to target the unhealthy bone marrow environment itself.
Therapies that reduce inflammation or restore a healthier marrow structure could potentially slow or even prevent the progression from CHIP to more serious conditions such as MDS and leukemia.
The research also highlights how many important changes occur silently inside the body long before symptoms appear. People may feel healthy while complex cellular processes are already increasing disease risk. Understanding these hidden changes could help doctors identify high-risk individuals earlier and develop strategies to prevent disease before it becomes severe.
The study offers a new way of thinking about blood disorders and aging. Rather than viewing disease as a problem caused only by abnormal cells, it shows that the environment surrounding those cells can be equally important.
By learning more about this hidden world inside our bones, scientists hope to develop better ways to protect healthy blood production and reduce the risk of dangerous blood cancers as people grow older.
If you care about cancer, please read studies that a low-carb diet could increase overall cancer risk, and vitamin D supplements could strongly reduce cancer death.
For more information about health, please see recent studies about how drinking milk affects the risks of heart disease and cancer and results showing higher intake of dairy foods linked to higher prostate cancer risk.
The study was published in the journal Nature Communications.
Copyright © 2026 Knowridge Science Report. All rights reserved.
